Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 352 entries
View as:

CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12

Phase: N/A Priority: Normal
NCT ID: NCT01095510 Org: User:
Start: 06/02/10 End: 04/17/12 Due: 04/17/13

An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy

Phase: N/A Priority: Normal
NCT ID: NCT01887938 Org: User:
Start: 05/23/13 End: 09/30/25 Due: 09/30/26

A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt)

Phase: N/A Priority: Normal
NCT ID: NCT01905540 Org: User:
Start: 08/05/13 End: 09/20/13 Due: 09/20/14

Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01890785 Org: User:
Start: 07/15/13 End: 08/22/13 Due: 08/22/14

Prevention of Recurrence of Diverticulitis

Phase: N/A Priority: Normal
NCT ID: NCT00545103 Org: User:
Start: 12/06/07 End: 11/28/11 Due: 11/28/12

Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01786876 Org: User:
Start: 03/07/13 End: 04/12/13 Due: 04/12/14

Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00875017 Org: User:
Start: 04/20/09 End: 06/16/09 Due: 06/16/10

Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)

Phase: N/A Priority: Normal
NCT ID: NCT00262080 Org: User:
Start: 12/31/05 End: 02/28/07 Due: 02/28/08

SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01718509 Org: User:
Start: 11/26/12 End: 09/20/13 Due: 09/20/14

Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT00915343 Org: User:
Start: 08/21/07 End: 01/28/09 Due: 01/28/10

Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00497796 Org: User:
Start: 07/23/07 End: 09/14/09 Due: 09/14/10

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

Phase: N/A Priority: Normal
NCT ID: NCT02412787 Org: User:
Start: 04/14/15 End: 04/18/24 Due: 04/18/25

Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

Phase: N/A Priority: Normal
NCT ID: NCT00630747 Org: User:
Start: 09/13/04 End: 01/31/08 Due: 01/31/09

Study of Teduglutide in Japanese Participants With Short Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03663582 Org: User:
Start: 07/06/18 End: 08/06/19 Due: 08/06/20

Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT01124643 Org: User:
Start: 04/13/10 End: 07/08/13 Due: 07/08/14

Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT00819468 Org: User:
Start: 07/26/07 End: 08/23/07 Due: 08/23/08

A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT03878953 Org: User:
Start: 08/31/22 End: 05/31/23 Due: 05/31/24

Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 Years

Phase: N/A Priority: Normal
NCT ID: NCT01424228 Org: User:
Start: 04/06/11 End: 12/19/12 Due: 12/19/13

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01328756 Org: User:
Start: 07/07/11 End: 09/30/14 Due: 09/30/15

Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants With Type 1 Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT02574286 Org: User:
Start: 06/29/16 End: 11/30/20 Due: 11/30/21

A Study for Patients With Neurogenic Orthostatic Hypotension

Phase: N/A Priority: Normal
NCT ID: NCT00046475 Org: User:
Start: 12/01/97 End: 11/24/99 Due: 11/24/00

Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01552928 Org: User:
Start: 03/29/12 End: 07/25/12 Due: 07/25/13

Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01760993 Org: User:
Start: 02/01/13 End: 04/01/13 Due: 04/01/14

A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT00430625 Org: User:
Start: 02/15/07 End: 04/01/09 Due: 04/01/10

Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008

Phase: N/A Priority: Normal
NCT ID: NCT00308438 Org: User:
Start: 03/01/04 End: 06/01/06 Due: 06/01/07